|
UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
|
FORM 8-K |
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 27, 2008
|
Bio-Reference Laboratories, Inc. |
|
(Exact name of registrant as specified in its charter) |
|
|
|
New Jersey |
0-15266 |
22-2405059 |
|
|
|
(State or other jurisdiction |
(Commission |
(IRS Employer |
of incorporation) |
File Number) |
Identification No.) |
|
481 Edward H. Ross Drive, Elmwood Park, NJ 07407 |
|
(Address of principal executive offices) (Zip Code) |
|
(201) 791-2600 |
|
Registrants telephone number, including area code |
|
|
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Bio-Reference Laboratories, Inc.
Form 8-K
February 27, 2008
Item 5.02 Compensatory Arrangements of Certain Officers
On February 27, 2008, the Registrant and Charles T. Todd, Jr. executed an amendment to Mr. Todds employment agreement. Mr. Todd is the Registrants Senior Vice President- Sales, and one of its five most highly compensated senior management employees. The amendment increased Mr. Todds base salary in fiscal 2008, effective February 1, 2008, from an annual rate of $395,000 to an annual rate of $528,420 (plus an adjustment based on an increase in the Consumer Price Index (CPI)) or an annual rate in fiscal 2008 of $540,000. As a result, Mr. Todds salary in fiscal 2008 will be $495,065 (plus a CPI adjustment of approximately $11,500).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
Bio-Reference Laboratories, Inc. |
|
|
|
|
|
By |
/s/ Marc D. Grodman |
|
|
|
|
|
Marc D. Grodman M.D. |
|
|
Principal Executive Officer |
|
|
|
Date: February 29, 2008 |
|
|